| 1 |
Skeletal Muscle |
Allogeneic – Related
|
Duchenne Muscular Dystrophy (DMD)
|
Genetic Disorder
|
2026
|
Experimental Therapy
|
Poland
|
14 |
| 2 |
Cord Tissue |
Allogeneic – Related
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
4 |
| 3 |
Cord Tissue |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
4 |
| 4 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
7 |
| 5 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
5 |
| 6 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
7 |
| 7 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
3 |
| 8 |
Cord Tissue |
Allogeneic – Unrelated
|
Cartilage Lesions
|
Orthopedics
|
2026
|
Experimental Therapy
|
Poland
|
67 |
| 9 |
Cord Tissue |
Allogeneic – Unrelated
|
Cartilage Lesions
|
Orthopedics
|
2026
|
Experimental Therapy
|
Poland
|
50 |
| 10 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
4 |
| 11 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
6 |
| 12 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
6 |
| 13 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
6 |
| 14 |
Cord Tissue |
Allogeneic – Unrelated
|
GvHD
|
Hematology
|
2026
|
Experimental Therapy
|
Poland
|
2 |
| 15 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
3 |
| 16 |
Cord Tissue |
Allogeneic – Unrelated
|
Cartilage Lesions
|
Orthopedics
|
2026
|
Experimental Therapy
|
Poland
|
60 |
| 17 |
Cord Tissue |
Allogeneic – Unrelated
|
GvHD
|
Hematology
|
2026
|
Experimental Therapy
|
Poland
|
5 |
| 18 |
Cord Tissue |
Allogeneic
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
United Arab Emirates
|
6 |
| 19 |
Cord Tissue |
Allogeneic – Unrelated
|
GvHD
|
Hematology
|
2026
|
Experimental Therapy
|
Poland
|
4 |
| 20 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
4 |
| 21 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
8 |
| 22 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
3 |
| 23 |
Cord Tissue |
Autologous
|
Cerebral Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
2 |
| 24 |
Cord Tissue |
Allogeneic – Related
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
6 |
| 25 |
Cord Tissue |
Allogeneic – Related
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
13 |
| 26 |
Cord Tissue |
Allogeneic – Related
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
8 |
| 27 |
Cord Tissue |
Allogeneic – Related
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
9 |
| 28 |
Cord Tissue |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
8 |
| 29 |
Cord Tissue |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
5 |
| 30 |
Cord Tissue |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
3 |
| 31 |
Cord Tissue |
Allogeneic – Related
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
3 |
| 32 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
7 |
| 33 |
Cord Tissue |
Allogeneic – Unrelated
|
Optic Atrophy
|
Ophthalmology
|
2026
|
Experimental Therapy
|
Poland
|
76 |
| 34 |
Cord Tissue |
Allogeneic – Unrelated
|
Encephalitis, Myelitis
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
36 |
| 35 |
Cord Tissue |
Allogeneic – Unrelated
|
Stress Incontinence
|
Urology
|
2026
|
Experimental Therapy
|
Poland
|
62 |
| 36 |
Cord Tissue |
Allogeneic – Unrelated
|
aGvHD, PNH
|
Hematology
|
2026
|
Experimental Therapy
|
Poland
|
17 |
| 37 |
Cord Tissue |
Allogeneic – Unrelated
|
Progressive Bulbar Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
58 |
| 38 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
6 |
| 39 |
Cord Tissue |
Allogeneic – Unrelated
|
Spinocerebellar Ataxia
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
59 |
| 40 |
Cord Tissue |
Allogeneic – Unrelated
|
aGvHD
|
Hematology
|
2026
|
Experimental Therapy
|
Poland
|
15 |
| 41 |
Cord Tissue |
Allogeneic – Unrelated
|
aGvHD
|
Hematology
|
2026
|
Experimental Therapy
|
Poland
|
12 |
| 42 |
Cord Tissue |
Allogeneic – Unrelated
|
aGvHD
|
Hematology
|
2026
|
Experimental Therapy
|
Poland
|
10 |
| 43 |
Cord Tissue |
Allogeneic – Unrelated
|
MSA, Multiple System Atrophy
|
Neurology
|
2026
|
Experimental Therapy
|
Centrum Medyczne Klara Częstochowa
|
53 |
| 44 |
Cord Tissue |
Allogeneic – Unrelated
|
Stress Incontinence
|
Gynecology
|
2026
|
Experimental Therapy
|
Szpital Uniwersytecki w Krakowie ul. Mikołaja Kopernika
|
79 |
| 45 |
Cord Tissue |
Allogeneic – Unrelated
|
Progressive Bulbar Palsy
|
Neurology
|
2026
|
Experimental Therapy
|
Centrum Medyczne Klara Częstochowa
|
65 |
| 46 |
Cord Tissue |
Allogeneic – Unrelated
|
MSA, Multiple System Atrophy
|
Neurology
|
2026
|
Experimental Therapy
|
Centrum Medyczne Klara Częstochowa
|
61 |
| 47 |
Cord Tissue |
Allogeneic Related
|
Spondylosis + Lumbar Disc Disease
|
Rheumatology
|
2026
|
Experimental Therapy
|
Slovakia , Malacky
|
32 |
| 48 |
Cord Tissue |
Autologus
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia , Malacky
|
3 |
| 49 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
4 |
| 50 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
8 |
| 51 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
5 |
| 52 |
Cord Blood |
Allogeneic – Unrelated
|
Acute Leukemia in remission, Pancytopenia after treatment
|
Hematology
|
2026
|
Standard Therapy
|
Denmark
|
18 |
| 53 |
Cord Blood |
Allogeneic – Related
|
Juvenile Myelomonocytic Leukemia (JMML)
|
Hematology
|
2026
|
Standard Therapy
|
Germany
|
10 |
| 54 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
6 |
| 55 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
7 |
| 56 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
5 |
| 57 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
4 |
| 58 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
8 |
| 59 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
7 |
| 60 |
Cord Blood |
Allogeneic
|
Thalassemia Major
|
Hematology
|
2026
|
Standard Therapy
|
Turkey
|
7 |
| 61 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
8 |
| 62 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
4 |
| 63 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
3 |
| 64 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
8 |
| 65 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
5 |
| 66 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia
|
3 |
| 67 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland
|
6 |
| 68 |
Cord Blood |
Allogeneic – Related
|
Diamond-Blackfan Anemia (DBA)
|
Hematology
|
2026
|
Standard Therapy
|
Germany
|
10 |
| 69 |
Cord Blood |
Autologus
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland, Lublin, Uniwersytecki Szpital Kliniczny
|
7 |
| 70 |
Cord Blood |
Autologus
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Poland, Lublin, Uniwersytecki Szpital Kliniczny
|
7 |
| 71 |
Cord Blood |
Autologus
|
Autism
|
Neurology
|
2026
|
Experimental Therapy
|
Slovakia , Malacky
|
3 |
| 72 |
Bone Marrow Family |
Allogeneic
|
T-Cell Lymphoma
|
Hematology
|
2026
|
Standard Therapy
|
Netherlands
|
65 |
| 73 |
Bone Marrow Family |
Allogeneic
|
Other Malignancy
|
Hematology
|
2026
|
Standard Therapy
|
France
|
51 |
| 74 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Italy
|
27 |
| 75 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
France
|
14 |
| 76 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
France
|
68 |
| 77 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
United Kingdom
|
43 |
| 78 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
USA
|
68 |
| 79 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
USA
|
69 |
| 80 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Germany
|
67 |
| 81 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2026
|
Standard Therapy
|
USA
|
64 |
| 82 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
USA
|
73 |
| 83 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
United Kingdom
|
26 |
| 84 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
USA
|
74 |
| 85 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Netherlands
|
66 |
| 86 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Romania
|
25 |
| 87 |
Bone Marrow Family |
Allogeneic
|
Other Myelofibrosis/Myelosclerosis
|
Hematology
|
2026
|
Standard Therapy
|
USA
|
65 |
| 88 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2026
|
Standard Therapy
|
Poland
|
62 |
| 89 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Germany
|
63 |
| 90 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Netherlands
|
47 |
| 91 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Czechia
|
67 |
| 92 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Sweden
|
74 |
| 93 |
Bone Marrow Family |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2026
|
Standard Therapy
|
Germany
|
72 |
| 94 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Ukraine
|
40 |
| 95 |
Bone Marrow Family |
Allogeneic
|
No Data
|
Hematology
|
2026
|
Standard Therapy
|
Germany
|
70 |
| 96 |
Bone Marrow Family |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
Hungary
|
35 |
| 97 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
USA
|
71 |
| 98 |
Bone Marrow Family |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2026
|
Standard Therapy
|
Poland
|
37 |
| 99 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2026
|
Standard Therapy
|
France
|
68 |
| 100 |
Bone Marrow Family |
Allogeneic
|
Fanconi Anemia
|
Hematology
|
2026
|
Standard Therapy
|
Germany
|
4 |